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Abstract
Background: The classification of HIV-1 strains in subtypes and Circulating Recombinant Forms (CRFs) has helped in
tracking the course of the HIV pandemic. In Senegal, which is located at the tip of West Africa, CRF02_AG predominates in
the general population and Female Sex Workers (FSWs). In contrast, 40% of Men having Sex with Men (MSM) in Senegal are
infected with subtype C. In this study we analyzed the geographical origins and introduction dates of HIV-1 C in Senegal in
order to better understand the evolutionary history of this subtype, which predominates today in the MSM population
Methodology/Principal Findings: We used a combination of phylogenetic analyses and a Bayesian coalescent-based
approach, to study the phylogenetic relationships in pol of 56 subtype C isolates from Senegal with 3,025 subtype C strains
that were sampled worldwide. Our analysis shows a significantly well supported cluster which contains all subtype C strains
that circulate among MSM in Senegal. The MSM cluster and other strains from Senegal are widely dispersed among the
different subclusters of African HIV-1 C strains, suggesting multiple introductions of subtype C in Senegal from many
different southern and east African countries. More detailed analyses show that HIV-1 C strains from MSM are more closely
related to those from southern Africa. The estimated date of the MRCA of subtype C in the MSM population in Senegal is
estimated to be in the early 80’s.
Conclusions/Significance: Our evolutionary reconstructions suggest that multiple subtype C viruses with a common
ancestor originating in the early 1970s entered Senegal. There was only one efficient spread in the MSM population, which
most likely resulted from a single introduction, underlining the importance of high-risk behavior in spread of viruses.
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Introduction
HIV-1 group M, which predominates in the global HIV/AIDS
epidemic, can be further subdivided into subtypes (A–D, F–H, J,
K), sub-subtypes (A1 to A4, F1 and F2), circulating recombinant
forms (CRF01 to CRF51) and numerous unique recombinant
forms (URFs) (www.hiv.lanl.gov). This genetic diversity has an
impact on almost all aspects of the management of this infection
going from identification and monitoring of infected persons, to
treatment efficacy and vaccine design [1–3]. The classification of
HIV strains has also helped in tracking the course of the HIV
pandemic [4]. Numerous molecular epidemiological studies
showed a heterogeneous geographic distribution of the different
HIV-1 M subtypes and CRFs. The initial diversification of group
M most likely occurred within or near the Democratic Republic of
Congo (DRC) [5,6], where the highest diversity of group M strains
has been observed and the earliest cases of HIV-1 infection (1959
and 1960) have been documented in Kinshasa, the capital city [7].
Different HIV variants have then spread across the world, and the
epidemics in the different continents and countries are the result of
different founder effects. Today, subtype C accounts for 50% of all
infections [8]. The majority of subtype C infections are found in
southern Africa where they represent almost 100% of circulating
HIV-1 strains. Subtype C also predominates in India, Ethiopia
and southern China, and has entered East Africa, Brazil, and
many European countries. With increasing mobility and human
migration, HIV-1 variants inevitably intermix in different parts of
the world and the distribution of the different HIV-1 variants is a
dynamic process.
In Senegal, which is located at the tip of West Africa, both
AIDS viruses, HIV-1 and HIV-2, co-circulate. HIV-2 was first
described in Senegal, but like in other West African countries, the
prevalence of HIV-2 remained low and is decreasing [9,10].
Today HIV-1 predominates and since the description of the first
HIV-1 AIDS case in 1986, HIV-1 seroprevalence remains below
1% in the general population but can reach up to 20% in
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(FSWs) or men having sex with men (MSM) [11]. Several studies
showed that CRF02_AG predominates in Senegal, representing
50–70% of circulating strains in the general population and FSWs,
but in contrast to surrounding west African countries, a wide
diversity of other HIV-1 variants co-circulate; subtypes A1, A3, B,
D, F, G, H, CRF01, CRF06, CRF09, CRF11, CRF45 and HIV-1
group O have all been documented [10,12–14]. As mentioned
above, the distribution of HIV-1 subtypes/CRFs can differ
between geographic origins and between population groups.
Recently our studies showed that 40% of MSM in Senegal are
infected with subtype C, which is in strong contrast with 4% to
10% in the general population and FSWs [10,12–15]. The factors
associated with the rapid spread of subtype C and its predomi-
nance in the global epidemic are not entirely known, but in certain
regions where it has been introduced, subtype C has overtaken
other HIV-1 variants [16]. The high prevalence and the rapid
spread of subtype C among MSM needs thus particular attention
because this could also lead to an increase overtime of subtype C
in the general population because more than 90% of MSM
recognize having sex with women [17].
Using a combination of phylogenetic analyses and a Bayesian
coalescent-based approach, we studied the phylogenetic relation-
ships of subtype C isolates from Senegal with other subtype C
strains that were sampled worldwide, in order to define the origin
and onset of the subtype C epidemic in MSM in Senegal.
Results
Origin of subtype C sequences in Senegal
Among the HIV-1 subtype C pol sequences that were
downloaded, we first eliminated all sequences that were not
identified as subtype C (i.e. intersubtype recombinants) by the
REGA-subtyping tool and kept only one isolate per patient. The
final dataset includes a total of 3,081 sequences spanning a
1,011 bp fragment in pol between positions 2,253 and 3,263 on
the HXB2 genome, including 56 (among which 24 MSM and 18
newly sequenced) strains from Senegal (Table 1 and Table S1).
Sequences were included from 4 different continents and 61
countries: Africa (22 countries), the Americas (7 countries), Asia (9
countries) and Europe (23 countries) (Table 2). The majority
(67.73%) of the sequences are from Africa and more precisely from
southern Africa (55.14%) that is South Africa (22.36%) and
Zambia (20.55%), and to a lower extent Botswana (4.32%),
Mozambique (3.18%), Malawi (2.30%), Swaziland (1.53%), and
Zimbabwe (0.91%). Subtype C sequences from Asia are
predominantly from India (355 sequences on a total of 380) and
those from the Americas mainly from southern Brazil (253
sequences on a total of 299). Subtype C sequences from Europe
represent 10.22% of the dataset and are collected from 23 different
countries, without a single country or area that predominates in
the dataset.
The maximum likelihood (PhyML) tree of the 3,081 subtype C
sequences is shown in Figure 1. The strains from Senegal are
highlighted in red, those from southern Africa (South Africa,
Zambia, Zimbabwe, Malawi, Mozambique, Botswana, and
Swaziland) in orange and those from the other African countries,
which are predominantly from East Africa, in yellow. Strains from
Asia, the Americas, and Europe are highlighted in green, purple
and blue respectively. The sequences from Senegal are inter-
spersed with the other African strains, but one significant cluster
(98.9% aLRT support), which comprised all sequences obtained
from MSM from Senegal, was identified. The phylogenetic tree
shows also separate clades for subtype C strains from southern
Africa and one from eastern Africa (cluster B, 75.9% aLRT
support), each of which contains sequences from Senegal. The tree
shows the presence of two other major clusters, one for the
majority of South American (cluster A, purple) and one for the
Asian strains (cluster C, green), each apparently resulting from
different single introductions, but no strain from Senegal was
observed in these clusters. The clusters from South America and
Asia are each supported by 72.7% and 82.3% aLRT values,
respectively. No significant cluster of European subtype C was
observed, they are all interspersed with strains from different
geographic origins mainly in Africa and in Asia and southern
America. In order to exclude the possibility of artifactual
phylogenetic clustering due to drug induced convergent evolution,
especially for the clades from Senegal, the phylogenetic tree
analysis was repeated on an alignment where 43 (i.e. 129 nt,
,12.7% of the full alignment) codon positions known to be
associated with major resistance mutations were removed. This
analysis shows the same subtype C clusters (Figure S1).
The above analysis showed that subtype C was introduced into
Senegal at multiple occasions. Figure 2 shows in more details the
subtype C sequences that are most closely related to those
observed in Senegal. As described in Materials and Methods, only
sequences that branched with one or more sequences from
Senegal until the second ancestral node in the phylogenetic tree of
the 3,081 sequences, were used for this subtree. In addition to the
56 sequences from Senegal, 121 other subtype C sequences were
included (Table S2), representing 5.7% of the total alignment.
Figure 2 shows the tree obtained by PhyML with strains colored
according to their geographic origin (the same tree with strain
names is available in Figure S2). HIV-1 strains from Zambia are
represented by a separate color in this tree because strains from
this country are frequently present. The majority of the subtype C
strains from Senegal and those from the MSM cluster (node C) are
falling in clusters (aLRT .85%) which are mainly represented by
strains from Zambia and other countries from southern Africa (for
example node A, E and F). Nevertheless, some strains from
Senegal are related to subtype C from east African countries
(majority Ethiopia: node D). Although the exact country at the
origin of the most recent common ancestor of the MSM strains
remains uncertain, this was most likely in southern Africa. The first
ancestral node to the MSM cluster (node B) suggests an origin in
Zambia, but this node is only supported with 83.7% aLRT and
11% bootstrap values. The first ancestral node (node A), supported
by an aLRT value of 94.7% and a bootstrap value of 49%,
contains mainly strains from Zambia but also from other southern
African countries. The Bayesian phylogenetic tree analysis
performed with MrBayes shows similar results (Figure S3).
Dating the subtype C epidemic in Senegal and MSM
population
We used a Bayesian MCMC approach implemented in
BEASTv1.6.1 to estimate the dates of the most recent common
ancestors (MRCAs) for the subtype C sequences from Senegal in
the general population and for the subtype C epidemic in the
MSM population. We used the Bayesian skyride population
growth model associated to three molecular clock models: strict,
relaxed uncorrelated lognormal, and relaxed uncorrelated expo-
nential. Moreover, we used four different priors on the average
substitution rate among branches with varying informative levels.
Figure 3 shows the resulting estimations of the MRCA dates for
the different models and priors used. More details are provided in
Table S3, including substitution rate estimations.
Bayes factors (BF) indicate that the relaxed exponential model
has a small advantage (BF in the 3 to 5 range) over the relaxed
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Strain identification Accession Number Year of isolation Population group Reference
90SN-90SE364 AY713416 1990 general population [53]
98SN-66HPD AJ583722 1998 general population [54]
99SN-159HALD AJ583716 1999 general population [54]
99SN-142HPD AJ583715 1999 general population [54]
98SN-39HALD AJ287005 1998 general population [55]
99SN-86HPD AJ583739 1999 general population [54]
04SN-MS003 FM210753 2004 MSM [15]
04SN-MS883 FM210752 2004 MSM [15]
04SN-MS855 FM210749 2004 MSM [15]
04SN-MS835 FM210745 2004 MSM [15]
04SN-MS821 FM210741 2004 MSM [15]
04SN-MS816 FM210740 2004 MSM [15]
04SN-MS779 FM210737 2004 MSM [15]
04SN-MS700 FM210736 2004 MSM [15]
04SN-MS540 FM210726 2004 MSM [15]
04SN-MS522 FM210725 2004 MSM [15]
04SN-MS492 FM210723 2004 MSM [15]
04SN-MS048 FM210722 2004 MSM [15]
04SN-MS481 FM210718 2004 MSM [15]
04SN-MS477 FM210717 2004 MSM [15]
04SN-MS475 FM210716 2004 MSM [15]
04SN-MS448 FM210712 2004 MSM [15]
04SN-MS422 FM210709 2004 MSM [15]
04SN-MS245 FM210699 2004 MSM [15]
04SN-MS029 FM210691 2004 MSM [15]
04SN-MS015 FM210689 2004 MSM [15]
04SN-MS011 FM210687 2004 MSM [15]
04SN-MS010 FM210686 2004 MSM [15]
04SN-MS007 FM210685 2004 MSM [15]
04SN-MS002 FM210684 2004 MSM [15]
03SN-980HALD FN599776 2003 general population [14]
03SN-965HALD FN599773 2003 general population [14]
02SN-510HALD FN599737 2002 general population [14]
99SN-67HDP FN599718 1999 general population [14]
09SN-SNA3-366 HM002544 2009 not known unpublished
08SN-SNA3-220 HM002517 2008 not known unpublished
08SN-SNA3-191 HM002515 2008 not known unpublished
07SN-SNA3-107 HM002507 2007 not known unpublished
02SN-260HALD HE588158 2002 general population this study
03SN-154HALD HE588157 2003 general population this study
03SN-321HALD HE588156 2003 general population this study
03SN-L065 HE588149 2003 general population this study
06SN-463HALD HE588155 2006 general population this study
07SN-2658HALD HE588150 2007 general population this study
07SN-2909HALD HE588151 2007 general population this study
07SN-2911HALD HE588152 2007 general population this study
07SN-2936HALD HE588153 2007 general population this study
07SN-3076HALD HE588154 2007 general population this study
00SN-102HALD HE588159 2000 general population this study
97SN-1119 HE588162 1997 general population this study
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6r a n g e )t h a nt h es t r i c tm o l e c u l a r clock. However, the relaxed
exponential model becomes non-informative when non- or
poorly informative priors on the substitution rate are used
(U[0,1] and N[2.5610
23,1 0 610
24], see Materials and
Methods), which reveals spurious peaks leading to very large
(up to ,400 years) 95% Highest Posterior Density (HPD)
intervals and unrealistic estimates. Except in these two cases, the
results with all models and priors are quite consistent. As
expected, when we used more informative priors we obtained
more restricted 95% HPD intervals. Nevertheless, the median
date estimates of the MRCAs of subtype C in the general
population of Senegal and for the MSM cluster are similar for
all models and priors, indicating likely epidemic origins in the
early 80’s, in the MSM population. The MRCA for the subtype
C strains that entered at multiple occasions into the general
population (i.e. heterosexual or mother to child transmission), is
estimated in the early 70’s.
To illustrate in more detail the MRCA of the subtype C strains
in the MSM population and their relation to the other HIV-1 C
strains from Senegal, the maximum clade credibility (MCC) tree
with time scale obtained from BEAST is shown in Figure 4. We
see the same MSM cluster as in the phylogeny of Figure 2 (see also
Figure S2 and S3), and the early 70’s and 80’s dates for the
MRCAs of general and MSM population respectively.
We verified whether presence of drug resistance mutations
could have an impact on MRCA dates and substitution rate
estimations. Therefore calculations were repeated on the three
different molecular clock models and for the four priors on an
alignment where 43 codon positions known to be associated with
major resistance mutations were removed. This analysis showed
no significant difference, compared to the results obtained with the
complete alignment (Table S3 for details on estimations and
Figure S4 for the MCC tree with time scale).
Finally, our reconstruction of the demographic history of HIV-1
C in Senegal identified an initial, slow growth phase until the end
of the 70’s followed by a period of quick exponential-like growth at
the end of the 90’s where the epidemic growth became slower
(Figure 5).
Discussion
In this study we analyzed the geographical origins and
introduction dates of HIV-1 subtype C in Senegal in order to
better understand the evolutionary history of this subtype which
predominates today in the MSM population [15]. Our evolution-
ary reconstructions suggest that multiple subtype C viruses with a
common ancestor originating in the early 1970s entered the
country, followed by a sharp growth of the effective number of
infections over the next decade.
This analysis of more than 3,000 globally collected reference
sequences most likely provides an adequate representation of
global subtype C diversity, and provides also additional informa-
tion on the subtype C epidemic in other continents. The
phylogenetic tree analysis showed several major clusters of subtype
C sequences, mainly related to the continent of origin, like Asia,
Southern America or Africa, except for Europe. Interestingly,
among the African strains, a separate cluster of strains derived
from patients living in east African countries was observed [18],
and subtype C strains from Europe do not form a separate cluster
and are interspersed among the different continents and major
clusters. Our data also confirm the previously reported link of the
subtype C epidemic in Brazil with east Africa [19–22].
Our analyses with various methods (PhyML, MrBayes and
BEAST) showed a significantly well-supported cluster which
contained all subtype C strains that circulate among MSM in
Senegal. The MSM cluster and other strains from Senegal are
widely dispersed among the different subclusters of African strains,
suggesting multiple introductions of subtype C into Senegal from
many different southern and also eastern African countries. More
detailed analyses showed that the majority of the HIV-1 C strains
from Senegal, including those circulating among MSM, are more
closely related to strains from southern African countries, mainly
Zambia. The cluster of subtype C strains derived from the MSM
population includes also strains from HIV-1 infected men from
Senegal, who were not identified as MSM. Homosexuality is illegal
in Senegal and male-to-male sex is condemned by political and
religious authorities and by the general population, therefore most
MSM keep their sexual life secret, including from their own family
and more than 90% of MSM reported having sex also with
women [17]. Thus, these additional strains in the MSM cluster are
most likely from individuals with male-to-male sex activities.
Subtype C in MSM may have its origin directly from southern
Africa but it is also possible that the ancestor of this subtype C
cluster circulated already for a certain period in the general
population in Senegal before it was introduced into the MSM
group.
The wide diversity and multiple introductions of subtype C fit
also with the distribution of the HIV-1 variants in the general
population in Senegal. Several studies showed that in addition to
CRF02_AG, many other HIV-1 subtypes and CRFs are also
present in the country, reflecting multiple introductions [10,12–
14]. This is most likely related to the important trading activity
and travel links of the country with many other African countries
[23,24]. Our estimates suggest that the MRCA of the subtype C
strains that entered Senegal was in the early 1970’s, about 10–15
years before the description of the first HIV-1 AIDS case in the
country or the first HIV-1 subtype C strain in 1988 in Senegal
[25]. The MRCA date estimate of subtype C in Senegal is
Table 1. Cont.
Strain identification Accession Number Year of isolation Population group Reference
02SN-478HALD HE588163 2002 general population this study
97SN-14Fann HE588165 1997 general population this study
97SN-25Fann HE588164 1997 general population this study
96SN-1083 HE588166 1996 general population this study
97SN-1186 HE588161 1997 general population this study
97SN-1189 HE588160 1997 general population this study
doi:10.1371/journal.pone.0033579.t001
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1966 for subtype C in Ethiopia [26], beginning of the 70’s for
Zimbabwe [27] or in the late 60’s for Malawi [28]. As expected,
we found that MRCA of subtype C in Senegal is not specific,
because multiple introductions occurred, and our MRCA date
estimate corresponds most likely to those of subtype C strains
outside Senegal. In contrast to southern African countries, subtype
C did not become the predominant strain in Senegal and did only
spread efficiently in the MSM population, underlining the
importance of high risk behavior in spread of viruses [29]. The
MRCA of subtype C in the MSM population is estimated in the
early 80’s and is the result of a single introduction. This estimate
coincides with the period where the HIV-1 C epidemic started a
quick exponential-like growth phase in Senegal for nearly 15 years
according to the Bayesian skyride analysis.
Our study showed also that analysis of alignments with or
without codons that are associated with drug resistance did not
have a significant impact on phylogenetic clustering or on MRCA
date and substitution rate estimations. Among the different
molecular clock models used, Bayes factors suggested the use of
the relaxed exponential molecular clock above the most frequently
used relaxed lognormal molecular clock. However, the very large
confidence intervals and convergence problems with the expo-
nential model with poorly informative priors, and the almost
similar results with informative priors for both models are
probably at the basis for the preferential use of the relaxed
lognormal molecular clock model for HIV.
Previous studies suggest that subtype C could spread more
efficiently due to the predominance of CCR5 variants or a
stronger predisposition for localization in the female genital
mucosa than other subtypes, which may facilitate both vertical and
heterosexual transmission [30–33]. Increase of subtype C could
also have implications on treatment because other subtype C
specific mutations have been documented and commercial drug
resistance assays cannot correctly test subtype C infections [2,34–
Table 2. Numbers of HIV-1 subtype C strains from different
countries that were included in this study.
Continent Country Number %
Africa 2087 67.73
Botswana 133 4.32
Burundi 91 2.95
Democratic Republic of Congo 19 0.62
Djibouti 1 0.03
Equatorial Guinea 1 0.03
Eritrea 2 0.06
Ethiopia 99 3.21
Gabon 1 0.03
Kenya 4 0.13
Malawi 71 2.30
Mali 1 0.03
Mozambique 98 3.18
Niger 4 0.13
Senegal 56 1.82
Somalia 1 0.03
South Africa 689 22.36
Sudan 10 0.32
Swaziland 47 1.53
Tanzania 82 2.66
Uganda 16 0.52
Zambia 633 20.55
Zimbabwe 28 0.91
America 299 9.71
Argentina 8 0.26
Brazil 253 8.21
Cuba 25 0.81
Honduras 1 0.03
United States of America 9 0.29
Uruguay 2 0.06
Venezuela 1 0.03
Asia 380 12.33
China 7 0.23
India 355 11.52
Israe ¨l 5 0.16
Myanmar 1 0.03
Philippines 1 0.03
Russia 1 0.03
South Korea 2 0.06
Taiwan 1 0.03
Yemen 7 0.23
Europe 315 10.22
Austria 3 0.10
Belgium 35 1.14
Cyprus 8 0.26
Czech Republic 11 0.36
Danmark 21 0.68
Finland 6 0.19
Table 2. Cont.
Continent Country Number %
France 7 0.23
Georgia 1 0.03
Germany 7 0.23
Greece 3 0.10
Italy 22 0.71
Luxemburg 3 0.10
Norway 16 0.52
Poland 2 0.06
Portugal 28 0.91
Roumania 35 1.14
Slovakia 1 0.03
Spain 26 0.84
Sweden 64 2.08
Switzerland 2 0.06
The Netherlands 8 0.26
Ukraine 3 0.10
United Kingdom 3 0.10
Total 3081
doi:10.1371/journal.pone.0033579.t002
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women infected with subtype C had a higher viral load and lower
CD4 counts than those infected with subtypes A and D, which
could also have an impact on pathogenesis and transmission [37].
Therefore, it is important to continue to monitor HIV-1 subtype/
CRF distribution among different population groups in Senegal.
However, in order to be able to compare trends over time, such
studies should be organized in a standardized way. For example,
WHO proposed standardized protocols for surveillance of drug
resistance mutations in recently infected individuals [38]. These
studies can be combined with subtype/CRF characterization.
Because MSM reported having sex also with women, they could
potentially serve as a bridge between high-risk men and low-risk
women. This sexual mixing pattern might contribute in the future
to the subsequent increase of subtype C in the general population.
An increase from 4% in 2000 to almost 10% between 2000 and
2010 among the general population in Senegal has already been
observed, and subtype C sequences recently obtained from HIV-1
C infected women in 2011 that cluster within the clade of strains
from the MSM population have now been observed (Coumba
Toure Kane, unpublished results). Understanding the origins and
dispersal patterns of HIV-1 clades at regional and country levels is
Figure 1. Maximum likelihood phylogenetic tree based on 3,081 HIV-1 subtype C pol sequences. Maximum likelihood (PhyML)
phylogenetic tree based on 1,011 nucleotide sites of pol gene sequence (nucleotides 2,253–3,263 of HXB2 coordinates) from 3,081 HIV-1 subtype C
isolates. Sequences were isolated in the countries shown in Table 2. Sequences are colored to their region of origin: Senegal in red, Southern African
countries (South-Africa, Botswana, Malawi, Mozambique, Swaziland, Zambia and Zimbabwe) in orange, other African countries (mainly from the East)
in yellow, North and South America in purple, Asia in green and Europe in blue. The branch support (aLRT) of clade A, B, C and MSM are of 73%, 76%,
82% and 99% respectively.
doi:10.1371/journal.pone.0033579.g001
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Continuous monitoring of HIV variants seems necessary to adapt
treatment and vaccine strategies to be efficient against local and
contemporary circulating HIV variants.
Materials and Methods
Nucleotide sequence dataset
In order to increase the number of sequences and to cover a
wide geographic range, we used the pol region for our analysis. Pol
sequences are highly studied because they are the target of
antiretroviral drugs. A total of 56 subtype C pol gene sequences
from Senegal were used in this study. Thirty-eight were obtained
from the Los Alamos HIV sequence database (www.hiv.lanl.gov)
from previously published reports and eighteen were newly
characterized from ongoing molecular epidemiology and/or drug
resistance studies mainly in Dakar, the capital city of Senegal
(Table 1). We downloaded only sequences that were at least 1,000
nucleotides in length and spanning the genomic region which
covers protease and majority of RT in pol between positions
2,253–3,263 on the HXB2 genome. Sequences were from blood
samples collected between 1990 and 2009. In addition, all
available subtype C sequences spanning the same genomic region
and for which country of origin and sampling year were known,
were also downloaded from the Los Alamos HIV database (www.
hiv.lanl.gov). We then submitted all the sequences to the REGA
Figure 2. Maximum likelihood phylogenetic tree constructed from 56 HIV-1 C pol sequences from Senegal and 121 close relatives.
Detailed maximum likelihood (PhyML) phylogenetic tree constructed using 1,011 nucleotide sites of pol gene sequence (nucleotides 2,253–3,263 of
HXB2 coordinates) from 177 HIV-1 subtype C isolates from Senegal and close relatives (see text). Branch support values (bootstrap and aLRT) are
displayed (see figure legend). Colors indicate the geographic origin and sequences were isolated in the following countries: 56 in red from Senegal,
25 in orange from Zambia, 49 in yellow from southern Africa (Botswana 6; Mozambique 5; Swaziland 2; South Africa 35; Zimbabwe 1), 12 in green
from East Africa (Burundi 2; Ethiopia 9; Kenya 1; Sudan 2), 3 in blue from other African countries (DRC 1; Equatorial Guinea 1; Gabon 1) and 30 in black
from European and Asian countries (Belgium 4; China 1; Germany 2; Denmark 1; Spain 5; France 1; Greece 1; Israel 1; India 1; Italia 1; Luxembourg 1;
Norway 2; Portugal 2; Sweden 7).
doi:10.1371/journal.pone.0033579.g002
HIV-1 Subtype C in Senegal
PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33579Figure 3. Dating the subtype C epidemic in general and MSM populations in Senegal. Coalescent based estimations (BEAST) and 95%
highest posterior density (HPD) intervals of the MRCA dates of 56 HIV-1 subtype C pol sequences obtained from the general and the MSM population.
Results are displayed for all tested substitution rate priors and molecular clock models, except for relaxed exponential with both less informative
priors which provides very large 95% HPD intervals and shows convergence problems (see Table S3 for detailed results, including substitution rate
estimations).
doi:10.1371/journal.pone.0033579.g003
Figure 4. Bayesian tree with timescale of 56 HIV-1 C pol sequences from Senegal. Maximum clade credibility tree with time scale obtained
with BEAST using 1,011 nucleotide sites of pol gene sequences (nucleotides 2,253–3,263 of HXB2 coordinates) from 56 HIV-1 subtype C isolates from
Senegal. This tree is obtained using the relaxed uncorrelated lognormal molecular clock model and moderately informative substitution rate prior
(Normal: 2.5610
23,7.5610
24). Clades with posterior probabilities $95% are indicated by diamonds. MSM isolates are colored in red.
doi:10.1371/journal.pone.0033579.g004
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eventual intersubtype recombinants [39,40]. We selected one
sequence per individual when sequential sequences were available
or when sequences were epidemiologically linked by direct donor–
recipient transmission.
HIV-1 pol sequencing
The 18 new HIV-1 pol sequences were obtained with an in-
house technique as previously described [41]. Briefly, RNA was
extracted using the QIAamp Viral RNA extraction kit (Qiagen
SA, Courtabeauf, France) and processed for reverse transcription
polymerase chain reaction (RT-PCR) with the integrase specific
primer IN3 59-TCTATBCCATCTAAAAATAGTACTTTCCT-
GATTCC-39 using the Expand reverse transcriptase (Roche
Diagnostics, Meylan, France) according to the manufacturer’s
instructions. The resulting cDNA served as template in the
subsequent nested PCR reaction during which a 1,865 base pairs
fragment, corresponding to the protease and the first 440 amino
acids of the reverse transcriptase region of the pol gene, was
amplified with previously described primers and cycling conditions
using the Expand Long Template PCR system (Roche Diagnos-
tics, Meylan, France). The amplified HIV-1 nucleic acid fragments
were purified using the Geneclean Turbo Kit (Q-Biogen,
MPbiomedicals, France) and directly sequenced with primers
encompassing the pol region using BigDye Terminator version 3.1
(Applied Biosystems, Courtaboeuf, France) according to the
manufacturer’s instructions. Electrophoresis and data collection
were done on an Applied Biosystems 3130XL Genetic Analyzer.
The sequenced fragments from both strands were reconstituted
using Seqman II from the DNAstar package v5.08 (Lasergene,
Madison, WI, USA).
Sequence alignment and phylogenetic tree analysis
The 18 newly obtained sequences were aligned with the
alignment of subtype C sequences downloaded from the Los
Alamos HIV database, using the L-INS-i method from MAFFT
[42,43], and then manually edited with MEGA5 [44]. The HXB2
subtype B prototype strain was used as outgroup. In order to study
potential bias due to drug-induced convergent evolution, all our
analysis were also repeated on an alignment for which we removed
43 codon positions known to be associated with major resistance
mutations according to the WHO-list of 2009 [45]. The following
positions were excluded for protease (23, 24, 30, 32, 46, 47, 48, 50,
53, 54, 73, 76, 82, 83, 84, 85, 88, 90) and RT (41, 65, 67, 69, 70,
74, 75, 77, 100, 101, 103, 106, 115, 116, 151, 179, 181, 184, 188,
190, 210, 215, 219, 225, 230), leaving 882 nt in the final
alignment. Both complete (1,011 nt) and restricted (882 nt)
sequence alignments are available from the authors upon request.
Maximum Likelihood phylogenies were inferred using the
GTR+I+C4 nucleotide substitution model recommended by [46]
and implemented in PhyML v3.0 [47]. The SPR option was
selected to search the tree space and aLRT SH-like branch
supports were used to assess confidence in topology [48]. The
phylogenetic tree was drawn with FIGTREE (tree.bio.ed.ac.uk/
software/figtree/).
In order to better determine and visualize the relationship of the
subtype C sequences from Senegal to those from other geographic
areas, another phylogenetic analysis was performed with less
sequences. For this subtree, we collected from the large, previous
phylogenetic tree, all descendant sequences of nodes that are first
or second level ancestor of at least one sequence from Senegal (i.e.,
all Senegalese sequences plus their sisters and close relatives). A
phylogeny was then inferred, using the same method and options
as described above, but in addition to aLRT we ran a non-
parametric bootstrap with 100 replicates to obtain a second
assessment of branch supports. A phylogenetic analysis on this
subset of sequences was also inferred using MrBayes v3.1 [49] with
the same substitution model as for the maximum likelihood tree,
and with chain length and tree sampling frequency of 5610
7 and
1610
4 generations, respectively. A burn-in of 2,000 sampled trees
(i.e. ,40%) was selected. By the end of the run, the average
Figure 5. Bayesian skyride plot of HIV-1 C demographic growth in Senegal using 56 pol sequences. Estimates of HIV-1 C effective
number of infections (Ne) over time from 56 Senegalese pol sequences using a Bayesian skyride plot in BEAST with relaxed uncorrelated lognormal
molecular clock and moderately informative substitution rate prior (ucld.mean Normal: 2.5610
23, 7.5610
24). The X-axis represents the time in year.
The Y-axis represents the HIV-1 effective number of infections (log10 scale). The black line marks the median estimate for Ne and the blue shadow
region displays the 95% highest posterior density (HPD) interval.
doi:10.1371/journal.pone.0033579.g005
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potential scale reduction factor of every parameter was in the
range [0.999, 1.001], except the parameter pinvar which is at
1.002, proving the convergence of the Markov chains (see
MrBayes manual).
Dating the introduction of subtype C in Senegal and
MSM population
Estimates of the substitution rate and dates of the most recent
common ancestor (MRCA) of subtype C in Senegal and in the
sub-epidemic in MSM were obtained using BEAST v1.6.1 [50].
The 56 pol gene subtype C sequences from Senegal were analyzed
under a GTR+I+C4 substitution process (as for phylogenetic
analyzes). We used three different molecular clock models (strict
clock, relaxed uncorrelated exponential and relaxed uncorrelated
lognormal) [51] as implemented in BEAST with a Bayesian
skyride tree prior as a coalescent demographic model with time-
aware smoothing [52]. For the parameters of each molecular clock
model (ucld.mean, uced.mean and clock.rate for the relaxed
lognormal, relaxed exponential and strict molecular clock
respectively) we tested a total of four different priors, one non-
informative prior based on a uniform distribution (between 0.0
and 1.0) and three priors with varying information levels based on
normal distribution with a mean of 2.5610
23 (based on
estimations from a previous study [27] in the same genomic
region and as estimated by Path-O-Gen: tree.bio.ed.ac.uk/
software/pathogen/) and standard deviations of 10610
24,
7.5610
24, and 5.0610
24, respectively. For the ucld.stdev
parameter (representing the variability of the rates among
branches for the relaxed lognormal molecular clock) we used a
prior based on an exponential distribution with mean of 0.1
(personal communication with A. Drummond). MCMC simula-
tions were run for 2.5610
8 chain steps with sub-sampling every
2.5610
5 steps. Convergence of the chains was inspected using
Tracer v.1.5. For each tested prior and for each parameter,
effective sample size (ESS) values were always above 300. The
Bayes Factor was calculated to compare molecular clock models,
using marginal likelihood as implemented in Tracer v.1.5. The
Maximum Clade Credibility with time scale (MCC) tree was
obtained by TreeAnnotator v1.6.1 with a burn-in of the first
hundred trees.
Supporting Information
Figure S1 Maximum likelihood phylogenetic tree based
on 3,081 HIV-1 subtype C pol sequences, without codons
associated to drug resistance in PR and RT. Maximum
likelihood phylogenetic tree (PhyML, with the same options as for
the tree in Figure 1) based on 882 nucleotide sites of pol gene
sequence from 3,081 HIV-1 subtype C isolates; nucleotide sites
with coordinates 2,253–3,263 of HXB2 are included, but codon
positions known to be associated with major resistance mutations
according to the WHO-list of 2009 were removed (see Materials
and Methods). Sequences were isolated in the countries shown in
Table 2. Sequences are colored according to their region of origin:
Senegal in red, Southern African countries (South-Africa,
Botswana, Malawi, Mozambique, Swaziland, Zambia and Zim-
babwe) in orange, other African countries (mainly from the East)
in yellow, North and South America in purple, Asia in green and
Europe in blue. The branch support (aLRT) of clades A, B, C and
MSM are respectively of 94%, 92%, 83% and 96%.
(JPG)
Figure S2 Maximum likelihood phylogenetic tree con-
structed of 56 HIV-1 C pol sequences from Senegal and
121 close relatives. Detailed maximum likelihood (PhyML)
phylogenetictreeconstructed using 1,011 nucleotide sitesof pol gene
sequence (nucleotides 2,253–3,263 of HXB2 coordinates) from 177
HIV-1 subtype C isolates from Senegal and close relatives (see
Materials and Methods) as shown in Figure 2 but names of the
strains are added. Branch support values (bootstrap and aLRT) are
displayed (see figure legend). Colors indicate the geographic origin
and sequences were isolated in the following countries: 56 in red
from Senegal, 25 in orange from Zambia, 49 in yellow from
southern Africa (Botswana 6; Mozambique 5; Swaziland 2; South
Africa 35; Zimbabwe 1), 12 in green from East Africa (Burundi 2;
Ethiopia 9; Kenya 1; Sudan 2), 3 in blue from other African
countries (DRC 1; Equatorial Guinea 1; Gabon 1) and 30 in black
from European and Asian countries (Belgium 4; China 1; Germany
2; Denmark 1; Spain 5; France 1; Greece 1; Israel 1; India 1; Italia
1; Luxembourg 1; Norway 2; Portugal 2; Sweden 7).
(TIFF)
Figure S3 Bayesian phylogenetic tree of 56 HIV-1 C pol
sequences from Senegal and 121 close relatives. Detailed
Bayesian phylogenetic tree (MrBayes, same model and similar
options as for the tree in Figure 2, see Materials and Methods)
constructed using 1,011 nucleotide sites of pol gene sequence
(nucleotides 2,253–3,263 of HXB2 coordinates) from 177 HIV-1
subtype C isolates from Senegal and close relatives. Clades with
posterior probabilities $95% are shown. Colors indicate the
geographic origin of the sequences, which were isolated in the
following countries: 56 in red from Senegal, 25 in orange from
Zambia, 49 in yellow from southern Africa (Botswana 6;
Mozambique 5; Swaziland 2; South Africa 35; Zimbabwe 1), 12
in green from East Africa (Burundi 2; Ethiopia 9; Kenya 1; Sudan
2), 3 in blue from other African countries (DRC 1; Equatorial
Guinea 1; Gabon 1) and 30 in black from European and Asian
countries (Belgium 4; China 1; Germany 2; Denmark 1; Spain 5;
France 1; Greece 1; Israel 1; India 1; Italia 1; Luxembourg 1;
Norway 2; Portugal 2; Sweden 7).
(TIFF)
Figure S4 Bayesian tree with timescale of 56 HIV-1 C
pol sequences from Senegal, without sites associated to
major, known resistance in PR and RT. Maximum clade
credibility tree with time scale obtained with BEAST using 1,011
nucleotide sites of pol gene sequences (nucleotides 2,253–3,263 of
HXB2 coordinates) from 56 HIV-1 subtype C isolates from
Senegal. This tree is obtained using the relaxed uncorrelated
lognormal molecular clock model and moderately informative
substitution rate prior (Normal: 2.5610
23, 7.5610
24). Clades with
posterior probabilities $95% are indicated by diamonds. MSM
isolates are colored in red.
(TIFF)
Table S1 Genbank accession numbers per country of
subtype C HIV-1 strains included in the study.
(DOC)
Table S2 Details of the strains included in the restricted
phylogenetic tree analysis from Figures 2, S2 and S3.
(PDF)
Table S3 Dating the subtype C epidemic in general and
MSM populations in Senegal. Coalescent based estimations
(BEAST) and 95% highest posterior density (HPD) intervals of the
MRCA dates and substitution rates of 56 HIV-1 subtype C pol
sequences obtained from the general and the MSM population.
Results are displayed for all tested substitution rate priors and
molecular clock models.
(PDF)
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